4.7 Article

Pathological Role of Phosphoglycerate Kinase 1 in Balloon Angioplasty-Induced Neointima Formation

期刊

出版社

MDPI
DOI: 10.3390/ijms22168822

关键词

hypoxia; neointimal formation; phosphoglycerate kinase 1; platelet-derived growth factor receptor-beta; vascular smooth muscle cells

资金

  1. Taipei Medical University [TMU102AE1-B15]
  2. China Medical University [CMU97-079]
  3. Ministry of Science and Technology of Taiwan [NSC95-2320-B-039-031-MY1/2, NSC97-2320-B-039-013-MY 1/2/3, MOST108-2320-B038-040-MY3]
  4. Taiwan Department of Health Cancer Research Center of Excellence [DOH100TD-C-111-005]

向作者/读者索取更多资源

PGK1 plays a role in promoting neointima formation under hypoxic conditions, and its inhibition may have a beneficial effect in preventing restenosis by suppressing vascular smooth muscle cell proliferation and migration. Blocking the PDGFRB pathway can also reduce PGK1 expression and have a significant impact on neointimal hyperplasia.
Restenosis is a common vascular complication after balloon angioplasty. Catheter balloon inflation-induced transient ischemia (hypoxia) of local arterial tissues plays a pathological role in neointima formation. Phosphoglycerate kinase 1 (PGK1), an adenosine triphosphate (ATP)-generating glycolytic enzyme, has been reported to associate with cell survival and can be triggered under hypoxia. The purposes of this study were to investigate the possible role and regulation of PGK1 in vascular smooth muscle cells (VSMCs) and balloon-injured arteries under hypoxia. Neointimal hyperplasia was induced by a rat carotid artery injury model. The cellular functions and regulatory mechanisms of PGK1 in VSMCs were investigated using small interfering RNAs (siRNAs), chemical inhibitors, or anaerobic cultivation. Our data indicated that protein expression of PGK1 can be rapidly induced at a very early stage after balloon angioplasty, and the silencing PGK1-induced low cellular energy circumstance resulted in the suppressions of VSMC proliferation and migration. Moreover, the experimental results demonstrated that blockage of PDGF receptor-beta (PDGFRB) or its downstream pathway, the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) axis, effectively reduced hypoxia-induced factor-1 (HIF-1 alpha) and PGK1 expressions in VSMCs. In vivo study evidenced that PGK1 knockdown significantly reduced neointima hyperplasia. PGK1 was expressed at the early stage of neointimal formation, and suppressing PGK1 has a potential beneficial effect for preventing restenosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据